Federally funded research largely continues in New Jersey, despite threats from the Trump administration to slash financial support for this work in ways critics say would be disastrous for science, public health and the state economy. But academic leaders, researchers and pharmaceutical executives and others remain deeply concerned about the potential for funding reductions from the National Institutes of Health, despite Monday’s temporary order from a federal judge halting the cuts. The NIH invested more than $405 million in 53 New Jersey-based projects in 2024, according to its grants database.
“The life that we’re lucky to live in America has been driven by the success of America’s research enterprise and our companies’ abilities to turn those discoveries into inventions that make our lives better,” said Michael Zwick, senior vice president for research at Rutgers University, which received about $250 million through NIH last year — the most for any New Jersey recipient — for work at its three campuses and various satellite institutes.
“We are facing fierce competition throughout the world” when it comes to scientific research, Zwick told NJ Spotlight News on Tuesday, and to reduce funding would be like “unilateral disarmament” and suggests the nation is “giving up” it’s commitment to this work. To read the full story.